top of page
​
​
HOME
ABOUT US
EXECUTIVE TEAM
ADVISORY BOARD
BOARD OF DIRECTORS
OUR PLATFORM
INVESTORS
NEWS
CONTACT
IMPRESSUM
Mehr
Use tab to navigate through the menu items.
News
Ymmunobio & Paul-Scherrer Institute win Innosuisse grant to develop radiopharmaceutical with YB-800
Jan 26
We are very proud to announce our 3rd place achievement at the Prix Galien USA Awards!
Nov 14, 2024
Countdown to the Prix Galien Awards: Showcasing Science-Driven Innovation in NYC!
Oct 31, 2024
READ MORE
Dr. Katrin Rupalla Interviewed by Global Business Reports
Apr 26, 2023
Drug Discovery & Development
Jan 31, 2023
Fierce Biotech: Appointment of Michel Janicot
Jan 13, 2023
SEE MORE NEWS
All Posts
Press Releases
In the News
Scientific Publications
Ymmunobio to Present at the Annual Meeting of the Association for Cancer Immunotherapy (CIMT)
Presentation to focus on mechanism of action of anti-tumor activity for lead asset YB-200 RIEHEN, SWITZERLAND, April 26, 2023 ─...
Apr 26, 2023
NEWS
Our science is making news.
Stay in touch.
Follow us on
LinkedIn
.
Join our mailing list
Email
Subscribe
Thanks for subscribing!
bottom of page
